Featured Research

from universities, journals, and other organizations

Toward Prevention Of A Common Complication Of Cataract Surgery

Date:
August 15, 2007
Source:
American Chemical Society
Summary:
A newly developed method for coating the intraocular lenses used in millions of cataract surgery procedures may prevent a common complication of cataract surgery, according to a new report. Such surgery corrects the vision loss that occurs when the lens of the eye becomes clouded.

A cataract is a clouding of the lens in the eye that affects vision. Most cataracts occur in older persons. By age 80, more than half of all people in the United States either have a cataract or have had cataract surgery.
Credit: Courtesy of NIH/National Eye Institute

A newly developed method for coating the intraocular lenses (IOLs) used in millions of cataract surgery procedures may prevent a common complication of cataract surgery, according to a new report. Such surgery corrects the vision loss that occurs when the lens of the eye becomes clouded.

Christine Jιrτme and colleagues report development of a method for applying a polyethylene glycol coating to IOLs. In laboratory experiments, researchers showed that the coating reduced accumulation of the protein film and adhesion of cells responsible for formation of secondary cataracts.

The coating did not affect the optical properties of the lens. It also could be applied to certain other surfaces in order to discourage undesirable protein accumulation and adhesion of cells, the report states.

During the operation, a small incision in the front of the lens capsular bag is used to remove the clouded crystalline lens. The IOL is inserted into the empty capsular bag. Researchers noted that IOL replacement surgery is a safe and well-established procedure to correct the vision loss from a cataract. In about 25 percent of cases, however, the back portion of the capsule eventually becomes clouded with a "secondary" cataract. Jιrτme notes that treatment is available for secondary cataracts, but describes it as risky.

The article "Improved Performances of Intraocular Lenses by Poly(ethylene glycol) Chemical Coatings" is scheduled for the Aug. 13 issue of ACS' Biomacromolecules.


Story Source:

The above story is based on materials provided by American Chemical Society. Note: Materials may be edited for content and length.


Cite This Page:

American Chemical Society. "Toward Prevention Of A Common Complication Of Cataract Surgery." ScienceDaily. ScienceDaily, 15 August 2007. <www.sciencedaily.com/releases/2007/08/070813102442.htm>.
American Chemical Society. (2007, August 15). Toward Prevention Of A Common Complication Of Cataract Surgery. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2007/08/070813102442.htm
American Chemical Society. "Toward Prevention Of A Common Complication Of Cataract Surgery." ScienceDaily. www.sciencedaily.com/releases/2007/08/070813102442.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) — The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) — The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) — The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) — In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins